Cytek BiosciencesCTKB
那斯達克 · USD
4.40
+0.03
(+0.69%)
收盤 02/27 04:59 (UTC+8)
盤後
4.30
4.30
(-2.27%)
02/27 04:59 (UTC+8)
Cytek BiosciencesCTKB
4.40
+0.03
(+0.69%)
財務數據
損益表
- 0.48
- 0.58
- 0.45
- 0.47
- 0.52
- 0.57
- 0.41
- 0.46
- 0.52
- 0.62
- -3.40
- 21.32
- -22.96
- 3.92
- 10.47
- 11.60
- -27.87
- 10.00
- 14.67
- 18.83
- 營業收入(億)
- 季增長率(%)
單位：美元千元
2025/Q4 | 2025/Q3 | 2025/Q2 | 2025/Q1 | 2024/Q4 | 2024/Q3 | 2024/Q2 | 2024/Q1 | 2023/Q4 | 2023/Q3 | |
營業收入淨額 | 62,141 | 52,293 | 45,602 | 41,457 | 57,476 | 51,500 | 46,617 | 44,860 | 58,233 | 48,001 |
營業成本 | - | 24,742 | 21,735 | 21,300 | 23,824 | 22,495 | 21,181 | 21,847 | 25,185 | 20,823 |
營業毛利 | 32,885 | 27,551 | 23,867 | 20,157 | 33,652 | 29,005 | 25,436 | 23,013 | 33,048 | 27,178 |
營業費用 | - | 36,743 | 34,490 | - | - | - | - | - | 33,185 | 33,597 |
研發費用 | - | 8,956 | 8,825 | 9,725 | 9,723 | 9,883 | 10,000 | 9,796 | 10,869 | 11,172 |
推銷及管理費用 | - | 27,787 | 25,665 | 25,407 | 20,943 | 23,371 | 23,962 | 23,951 | 22,316 | 22,425 |
非經常性項目費用 | - | - | - | - | - | - | - | - | - | - |
其他營業費用 | - | - | - | - | - | - | - | - | - | - |
營業利益 | -5,594 | -9,192 | -10,623 | -14,975 | 2,986 | -4,249 | -8,526 | -10,734 | -137 | -6,419 |
其他收入及費用 | - | 1,917 | 4,262 | 4,000 | 1,404 | 4,524 | 1,474 | 2,182 | 4,642 | 2,829 |
利息費用 | - | 494 | 414 | 291 | -694 | 119 | 134 | 441 | 394 | 595 |
稅前純益 | -4,031 | -7,769 | -6,775 | -11,266 | 10,323 | 156 | -7,186 | -8,993 | 4,111 | -4,185 |
所得稅 | 40,045 | -2,291 | -1,192 | 136 | 680 | -784 | 3,248 | -2,824 | -1,392 | 2,271 |
稅後純益 | -44,076 | -5,478 | -5,583 | -11,402 | 9,643 | 940 | -10,434 | -6,169 | 5,503 | -6,456 |
基本每股稅後盈餘(元) | -0.34 | -0.04 | -0.04 | -0.09 | 0.07 | 0.01 | -0.08 | -0.05 | - | -0.05 |
稀釋每股稅後盈餘(元) | -0.34 | -0.05 | -0.04 | -0.09 | 0.07 | 0.01 | -0.08 | -0.05 | 0.04 | -0.05 |
基本平均股數(千股) | 128163.00 | 127547.00 | 126934.00 | 128339.00 | 129082.00 | 131003.00 | 131440.00 | 130920.00 | - | 136173.00 |
稀釋平均股數(千股) | 128163.00 | 127547.00 | 126934.00 | 128339.00 | 127300.00 | 132785.00 | 131440.00 | 130920.00 | - | 136173.00 |
還原基本每股稅後盈餘(元) | -0.34 | -0.04 | -0.04 | -0.09 | 0.07 | 0.01 | -0.08 | -0.05 | - | -0.05 |
還原稀釋每股稅後盈餘(元) | -0.34 | -0.05 | -0.04 | -0.09 | 0.07 | 0.01 | -0.08 | -0.05 | 0.04 | -0.05 |
還原基本平均股數(千股) | 128,163 | 127,547 | 126,934 | 128,339 | 129,082 | 131,003 | 131,440 | 130,920 | - | 136,173 |
還原稀釋平均股數(千股) | 128,163 | 127,547 | 126,934 | 128,339 | 127,300 | 132,785 | 131,440 | 130,920 | - | 136,173 |
EBITDA(千元) | -4,031 | -4,074 | -3,229 | -7,943 | 4,666 | 3,149 | -4,426 | -5,791 | 7,196 | -551 |